This 3-day forum is the “must attend” event for those senior decision-makers looking to drive their medical affairs teams and departments and enhance their KOL & stakeholder engagement at all levels.

Along with our exclusivenetworking dinner for all participants, the event will feature excellent networking opportunities and the chance to strengthen your contacts within the Medical Affairs community. The 2018 event was a sell-out so please make sure you book early to avoid disappointment.

Why Attend in 2019?

This event will enable you to:

  1. Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what needs to be done to maximise success.
  2. Discover which are the most intelligent ways to map and engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
  3. Measure the performance of your medical affairs team and individuals.
  4. Benchmark with experts to find out the best practices in late phase research, especially observational studies, patient registries and investigator-initiated studies.
  5. Discover how medical scientific liaisons, in support of commercial teams, are crucial to the communication of effectiveness, safety and cost effectiveness.
  6. Learn how the medical affairs role can engage KOLs & enhance value for medical devices due to their unique product lifecycle and characteristics.
  7. Get real-life experiences of medical affairs capabilities development in smaller Pharma, Biotech & MedTech companies.
Request agenda here for complete speaker list

Industry experts: Large & Medium Pharma

Vice President and Head of External Engagement & Policy Neurology Patient Value Unit
UCB, USA

MSL Director Region Europe.
Novartis Oncology, Spain

Vice President, Global Medical Affairs Head, Respiratory
Sanofi, USA

Vice-President, Global Medical Affairs Services
Ipsen Pharma, Spain

Head of Real-World Evidence, EMEA
Janssen, Pharmaceutical Companies of Johnson and Johnson, Belgium

Senior Director, Enterprise Benefit Risk Medical Director
Pfizer, USA

Country Medical Director BeNeLux, Management Board Member
Janssen, Pharmaceutical Companies of Johnson and Johnson, Netherlands

Senior Director, Global Medical Science Liaison
Philips, USA

Global Therapeutic Area Medical Affairs Director, Rheumatology
Pfizer, USA

EMEA Medical Affairs Director
Merck Group, Poland

Customer Facing Medical (MSL) Effectiveness Lead Europe Medical Affairs
Pfizer, UK

Senior Medical Director, US Medical Affairs Lead – Neuroscience
Otsuka Pharmaceutical Development and Commercialization, USA

Associate Medical Director MSL and Digital Transformation
Teva Pharmaceuticals, Netherlands

Director, Biostatistics
Celgene, USA

General Medicine Clinical Director European Clinical Development Team
MSD, Poland

Medical Operations, Training & Development Manager; Insights Discovery Practitioner
Janssen, Pharmaceutical Companies of Johnson and Johnson, Netherlands
 

Industry experts: Smaller Pharma, Biotech & MedTech

Head Medical Affairs Global Medical and Scientific Affairs CPS
Roche Diagnostics International, Switzerland

SVP Head Clinical Development
BTG International

Vice President Medical Affairs
Pharming Group, Netherlands

Head of Medical Affairs
Almirall, UK

Medical Director CEEMERIT
Kyowa Kirin Pharma, Czech Republic

Vice President Medical Affairs
Gelesis, USA

Head of Medical Affairs, International
ViiV Healthcare, UK

Head NASH International Medical Affairs
Intercept Pharma, UK

Senior Director Medical Affairs - Specialty Products
Ferring Pharmaceuticals, USA

 

External Stakeholders

President
European Medical Association, Belgium

Associate Director of Medicines Optimisation, DGS & Swale CCGs
NHS, UK

General Health Scientist, Senior Scientific Program Manager
FDA

CEO
Patient View, UK

Managing Director
Center for Research and Interdisciplinarity (CRI), France

Digital Health Innovation Manager
Bayer Business Services

 

Experienced Solution Provider

CEO, Head of Clinical Services, Senior Executive Coach
Pinnacle Wellbeing 247

Request agenda here for complete speaker list

Pictures from recent MedAffairs Leaders Forum. Imagine being there...

The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.

SPEAKER LIST - DAY 1

Vice President and Head of External Engagement & Policy Neurology Patient Value Unit
UCB, USA

Country Medical Director BeNeLux, Management Board Member
Janssen, Pharmaceutical Companies of Johnson and Johnson, Netherlands

Senior Director, Global Medical Science Liaison
Philips, USA

Vice-President, Global Medical Affairs Services
Ipsen Pharma, Spain

Senior Medical Director, US Medical Affairs Lead – Neuroscience
Otsuka Pharmaceutical Development and Commercialization, USA

Global Therapeutic Area Medical Affairs Director, Rheumatology
Pfizer, USA

Managing Director
Center for Research and Interdisciplinarity (CRI), France

President
European Medical Association, Belgium

CEO
Patient View, UK

 

Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders.

SPEAKER LIST - DAY 2 - STREAM 1

Vice President, Global Medical Affairs Head, Respiratory
Sanofi, USA

Head of Real-World Evidence, EMEA
Janssen, Pharmaceutical Companies of Johnson and Johnson, Belgium

General Medicine Clinical Director European Clinical Development Team
MSD, Poland

SVP Head Clinical Development
BTG International

Managing Director
Center for Research and Interdisciplinarity (CRI), France

Digital Health Innovation Manager
Bayer Business Services

General Health Scientist, Senior Scientific Program Manager
FDA

Associate Director of Medicines Optimisation, DGS & Swale CCGs
NHS, UK

Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements. The day will also feature best practice case studies on structuring, managing, and monitoring the evolving Medical Science Liaison role within your organisation. This meeting is an ideal chance to benchmark with other market leaders in this field who are utilising the unique MSL function to more effectively communicate with external experts, engage them with advanced science and demonstrate product evidence. All attending will discovery how MSLs can help regain the credibility of the pharmaceutical industry as a value-adding partner to the healthcare ecosystem.

SPEAKER LIST - DAY 2 - STREAM 2

MSL Director Region Europe.
Novartis Oncology, Spain

Senior Director, Enterprise Benefit Risk Medical Director
Pfizer, USA

Country Medical Director BeNeLux, Management Board Member
Janssen, Pharmaceutical Companies of Johnson and Johnson, Netherlands

Director, Biostatistics
Celgene, USA

Customer Facing Medical (MSL) Effectiveness Lead Europe Medical Affairs
Pfizer, UK

Associate Medical Director MSL and Digital Transformation
Teva Pharmaceuticals, Netherlands

Medical Operations, Training & Development Manager; Insights Discovery Practitioner
Janssen, Pharmaceutical Companies of Johnson and Johnson, Netherlands

 

  • Building an effective, medical affairs team with limited resources, that adds-value to external stakeholders
  • Determining what capabilities, skills, resources and team structure is realistically required to maximise performance
  • Cultural change: Transformation to a patient and stakeholder-centric organization, that is science-led.
  • Maximisation of real-world evidence generation on limited budgets
  • Leveraging both classical and digital medical communication strategies with a small team to maximise dialogue with KOLs and stakeholders
  • Demonstrating the value of medical affairs to internal stakeholders
SPEAKER LIST - DAY 3 - STREAM A

Vice President Medical Affairs
Pharming Group, Netherlands

Head Medical Affairs Global Medical and Scientific Affairs CPS
Roche Diagnostics International, Switzerland

Head of Medical Affairs
Almirall, UK

Vice President Medical Affairs
Gelesis, USA

Medical Director CEEMERIT
Kyowa Kirin Pharma, Czech Republic

Head NASH International Medical Affairs
Intercept Pharma, UK

Senior Director Medical Affairs - Specialty Products
Ferring Pharmaceuticals, USA

 

The industry-leading ‘Charisma Masterclass for Medical Affairs Executives’ is the top personal effectiveness training program. It helps senior executives to uncover and utilize their latent inner power.

The Charisma Masterclass is uniquely tailored for entrepreneurs, business leaders and high potential professionals. Participants will learn to fast track ability to create the perfect first impression and to optimize each and every interaction. Register now and learn how to influence, persuade, and inspire.

Workshop Leader

  Richard Reid
CEO, Executive Coach & Psychologist
Pinnacle Wellbeing 247

PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:
Customer Relations, Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications,
Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Scientific Affairs, Medical Advisors and Patient-Centricity.

Event Partner

Media Partners

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Share with Colleagues